Targeting Sphingosine-1-Phosphate Axis in Obesity-Promoted Breast Cancer

Abstract

Obesity, which induces low-grade inflammation, is a known risk factor for worse prognosis in many cancers including breast. We found that sphingosine-1-phosphate (S1P) produced by sphingosine kinases (SphKs) plays a critical role in obesity-related inflammation and breast cancer. Obesity increased S1P in the tumor microenvironment, as well as in the primary tumors. FTY720, a functional antagonist of S1PR1, dramatically decreased cancer progression by reducing expressions of SphK1 and S1PR1, and inflammatory cytokines including IL-6. Our results suggest a critical role for S1P in obesity-related inflammation and FTY720, an S1P axis inhibitor, appears to be a promising treatment for breast cancer in the obese condition, could be due to its effect on reactivate ER-alpha expression and sensitize breast cancer cells to tamoxifen therapy.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
May 01, 2015
Accession Number
ADA621812

Entities

People

  • Dorit Avni

Organizations

  • Virginia Commonwealth University

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Alkenes
  • Biochemistry
  • Biological Sciences
  • Biology
  • Blood
  • Breast Cancer
  • Cells
  • Chemistry
  • Cytokines
  • Enzyme Inhibitors
  • Inflammation
  • Laser Therapy
  • Molecular Biology
  • Neoplasms
  • Proteins
  • Students

Readers

  • Breast cancer cell signaling and growth regulation.
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Molecular Biology and Genetics